Free provider profile
PAIGE DARGATZ, NP-C
NPI 1871022764
Individual
Nurse Practitioner, Family
Active registration
Save to rep workspaceNPI registry Registry record
Source: CMS NPPES registry, updated continuously. This record was last updated 2022-11-30.
2120 8TH AVE NE, ABERDEEN, SD, 57401
605-725-4772
Single practice location
Enumerated 2017-06-05
- — Registration is active in NPPES.
- — Individual clinician record — reachable, but usually not the buyer.
- — Practice phone number is published.
- — Full street address on file for route planning.
- — Record last updated 3 years ago.
Medicare Part D prescribing
Source: CMS Medicare Part D Prescribers by Provider, most recent public year.
Part D claims
1,950
Medicare patients
128
Part D drug cost
$229,128
Brand-name share
11.9%
of this prescriber's Part D claims
| Drug | Claims | Medicare cost |
|---|---|---|
| Ozempic (Semaglutide) | 68 | $90,606 |
| Mounjaro (Tirzepatide) | 47 | $48,838 |
| Jardiance (Empagliflozin) | 13 | $14,528 |
| Linzess (Linaclotide) | 12 | $9,223 |
| Praluent Pen (Alirocumab) | 11 | $5,478 |
| Dotti (Estradiol) | 64 | $4,447 |
| Progesterone (Progesterone, Micronized) | 64 | $3,856 |
| Liothyronine Sodium (Liothyronine Sodium) | 85 | $2,918 |
Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.
Spravato (esketamine) Medicare billing
Source: CMS Medicare Part B fee-for-service, HCPCS G2082/G2083.
202428 sessions · 12 patients · $21,635
Full Spravato label-compliance detail — sessions per patient against the FDA label, risk flags and year-over-year trend.
- Registry data comes straight from CMS NPPES, which lists registration, not activity — a listed practice may have moved or closed.
- Part D covers Medicare prescription drug enrollees only. Commercial, Medicaid and cash-pay prescribing is not included, so these figures are a floor on real volume, not the whole picture.
- CMS publishes the Part D file annually, roughly two years behind the prescribing year. Drugs with 10 or fewer claims are suppressed.